Answers are grounded in this paper and cite their sources.
Myxococcus sp. is an important large genus in the family of myxobacteria because it is considered a prospecting source of secondary metabolites. This study aims to: (i) Identify potential NC01 strain by morphological, biochemical and 16S rDNA gene sequences; (ii) Evaluate antimicrobial activity by agar well-diffusion and microdilution methods; (iii) Survey medium and fermentation conditions that exhibit the best antimicrobial activity and (iv) Determine active fractionation by thin-layer chromatography (TLC) bioautography. The results show that the NC01 strain was designated Myxococcus fulvus. This strain demonstrated inhibition in 9/10 of the strains tested with the most impressive activity being recorded on MSSA, A. niger and Penicillium sp. with a minimum inhibitory concentration of 1 μg/mL however this strain did not show inhibition of E. coli. The survey of fermentation conditions revealed the crude extract exhibited the best antimicrobial activity on medium P at pH 7.2, temperature 37 oC. The two segments No. 2 and No. 3 (Rf = 0.23 and Rf = 0.28) contain compounds that were active on A. niger.
No takes yet. Share an insight, caveat, or question.
Linh Thi Lan Dinh (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: